• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吸入性前列环素用于对吸入一氧化氮难治的足月儿持续性肺动脉高压

Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide.

作者信息

Kelly Lisa K, Porta Nicolas F m, Goodman Denise M, Carroll Christopher L, Steinhorn Robin H

机构信息

Department of Pediatrics, Children's Memorial Hospital and Northwestern University Medical School, Chicago, Illinois 60614, USA.

出版信息

J Pediatr. 2002 Dec;141(6):830-2. doi: 10.1067/mpd.2002.129849.

DOI:10.1067/mpd.2002.129849
PMID:12461501
Abstract

We report the use of inhaled prostacyclin (PGI(2)) in 4 neonates with persistent pulmonary hypertension and hypoxemia refractory to inhaled nitric oxide. Oxygenation rapidly improved after inhalation of PGI(2) in all infants. The condition of one infant subsequently deteriorated, and alveolar capillary dysplasia was found at autopsy. The surviving infants were discharged with normal oxygen saturations in room air.

摘要

我们报告了4例持续性肺动脉高压且对吸入一氧化氮治疗无效的低氧血症新生儿使用吸入性前列环素(PGI₂)的情况。所有婴儿吸入PGI₂后氧合迅速改善。其中一名婴儿的病情随后恶化,尸检发现肺泡毛细血管发育异常。存活的婴儿出院时在室内空气中血氧饱和度正常。

相似文献

1
Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide.吸入性前列环素用于对吸入一氧化氮难治的足月儿持续性肺动脉高压
J Pediatr. 2002 Dec;141(6):830-2. doi: 10.1067/mpd.2002.129849.
2
Intravenous prostacyclin combined with inhaled nitric oxide therapy for an infant with alveolar capillary dysplasia.静脉注射前列环素联合吸入一氧化氮治疗一名患有肺泡毛细血管发育不良的婴儿。
Pediatr Int. 2002 Oct;44(5):525-7.
3
Intravenous prostacyclin in the treatment of persistent pulmonary hypertension of the newborn refractory to inhaled nitric oxide.静脉注射前列环素治疗对吸入一氧化氮难治的新生儿持续性肺动脉高压
Isr Med Assoc J. 2005 Jun;7(6):408-9.
4
Persistent pulmonary hypertension of the newborn refractory to inhaled nitric oxide and prostacyclin, responsive to neuromuscular blockade.
Minerva Pediatr. 2011 Jun;63(3):233-5.
5
Current and future therapeutic options for persistent pulmonary hypertension in the newborn.新生儿持续性肺动脉高压的当前及未来治疗选择
Expert Rev Cardiovasc Ther. 2010 Jun;8(6):845-62. doi: 10.1586/erc.09.186.
6
Inhaled nitric oxide in the term newborn.足月儿吸入一氧化氮。
Early Hum Dev. 2008 Nov;84(11):709-16. doi: 10.1016/j.earlhumdev.2008.08.002. Epub 2008 Oct 19.
7
Use of inhaled nitric oxide for the treatment of persistent pulmonary hypertension of the newborn (PPHN).吸入一氧化氮用于治疗新生儿持续性肺动脉高压(PPHN)。
J Ky Med Assoc. 1999 Mar;97(3):100-4.
8
[Persistent pulmonary hypertension in premature and newborn infants: selective pulmonary vasodilation with inhaled nitric oxide (iNO)].[早产和新生儿持续性肺动脉高压:吸入一氧化氮(iNO)进行选择性肺血管扩张]
Z Geburtshilfe Neonatol. 1998 Jan-Feb;202(1):25-9.
9
Low-dose nitric oxide therapy for persistent pulmonary hypertension: 1-year follow-up.低剂量一氧化氮疗法治疗持续性肺动脉高压:1年随访
J Perinatol. 2003 Jun;23(4):300-3. doi: 10.1038/sj.jp.7210908.
10
Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement.二尖瓣置换术后肺动脉高压患者吸入前列环素、一氧化氮和硝普钠的研究
J Card Surg. 2005 Mar-Apr;20(2):171-6. doi: 10.1111/j.0886-0440.2005.200383w.x.

引用本文的文献

1
Omega-6 polyunsaturated fatty acids and their metabolites: a potential targeted therapy for pulmonary hypertension.ω-6多不饱和脂肪酸及其代谢产物:肺动脉高压的一种潜在靶向治疗方法。
Respir Res. 2025 Mar 15;26(1):102. doi: 10.1186/s12931-025-03172-2.
2
Safety and Tolerability of Continuous Inhaled Iloprost Therapy for Severe Pulmonary Hypertension in Neonates and Infants.持续吸入伊洛前列素治疗新生儿和婴儿重度肺动脉高压的安全性和耐受性
Children (Basel). 2024 Jun 7;11(6):703. doi: 10.3390/children11060703.
3
Case Report: Stüve-Wiedemann syndrome-a rare cause of persistent pulmonary hypertension of the newborn.
病例报告:施图韦-维德曼综合征——新生儿持续性肺动脉高压的罕见病因。
Front Pediatr. 2024 Jan 4;11:1329404. doi: 10.3389/fped.2023.1329404. eCollection 2023.
4
Current and emerging pharmacotherapies for the treatment of pulmonary arterial hypertension in infants.当前和新兴的肺动脉高压治疗药物治疗婴儿的肺动脉高压。
Expert Opin Pharmacother. 2023 Sep-Dec;24(17):1875-1886. doi: 10.1080/14656566.2023.2257598. Epub 2023 Sep 14.
5
Inhaled iloprost is an effective alternative therapy for persistent pulmonary hypertension in newborns.吸入伊洛前列素是治疗新生儿持续性肺动脉高压的一种有效替代疗法。
Pulm Circ. 2023 Jul 18;13(3):e12268. doi: 10.1002/pul2.12268. eCollection 2023 Jul.
6
Pharmacotherapy for Pulmonary Hypertension in Infants with Bronchopulmonary Dysplasia: Past, Present, and Future.支气管肺发育不良婴儿肺动脉高压的药物治疗:过去、现在与未来
Pharmaceuticals (Basel). 2023 Mar 28;16(4):503. doi: 10.3390/ph16040503.
7
Pulmonary vasodilator strategies in neonates with acute hypoxemic respiratory failure and pulmonary hypertension.新生儿急性低氧性呼吸衰竭和肺动脉高压的肺血管扩张剂治疗策略。
Semin Fetal Neonatal Med. 2022 Aug;27(4):101367. doi: 10.1016/j.siny.2022.101367. Epub 2022 Jun 3.
8
Persistent Pulmonary Hypertension: A Look Into the Future Therapy.持续性肺动脉高压:未来治疗展望
Cureus. 2021 Dec 13;13(12):e20377. doi: 10.7759/cureus.20377. eCollection 2021 Dec.
9
Evidence-Based Guidelines for Acute Stabilization and Management of Neonates with Persistent Pulmonary Hypertension of the Newborn.证据为基础的指南:新生儿持续肺动脉高压的急性稳定化和管理。
Am J Perinatol. 2023 Oct;40(14):1495-1508. doi: 10.1055/a-1711-0778. Epub 2021 Dec 1.
10
Pathophysiology and Management of Persistent Pulmonary Hypertension of the Newborn.新生儿持续性肺动脉高压的病理生理学和治疗管理。
Clin Perinatol. 2021 Aug;48(3):595-618. doi: 10.1016/j.clp.2021.05.009.